biota will enjoy all the spoils-the australian, page-24

No one runs a Phase III without being almost 100% certain it will be passed. Totally incorrect, you need to check your facts. Even those compounds meeting all end points of their pivotal trials still have a significant risk of FDA rejection. LANI has not even done P2. Yes it is de-risked, but there are still significant risks.

Didn't have the funding and so couldn't progress. (Excuse the paraphrase)
Totally wrong again. LANI could have been progressed for RoW without significant investment. Clearly Biota decided it was not worth investing in.

I'll stop there as y'all don't appear to want to have balance or informed discussion.

Yay Biota...go Biota, rocket to $10...

Over and out.